Dr. Reddy's Laboratories Limited

NSEI:DRREDDY Stock Report

Market Cap: ₹1.0t

Dr. Reddy's Laboratories Management

Management criteria checks 3/4

Dr. Reddy's Laboratories' CEO is Erez Israeli, appointed in Apr 2018, has a tenure of 7.58 years. directly owns 0.039% of the company’s shares, worth ₹409.56M. The average tenure of the management team and the board of directors is 7.6 years and 3.8 years respectively.

Key information

Erez Israeli

Chief executive officer

₹174.7m

Total compensation

CEO salary percentagen/a
CEO tenure7.6yrs
CEO ownership0.04%
Management average tenure7.6yrs
Board average tenure3.8yrs

Recent management updates

Recent updates

Benign Growth For Dr. Reddy's Laboratories Limited (NSE:DRREDDY) Underpins Its Share Price

Nov 21
Benign Growth For Dr. Reddy's Laboratories Limited (NSE:DRREDDY) Underpins Its Share Price

Here's Why Dr. Reddy's Laboratories (NSE:DRREDDY) Has Caught The Eye Of Investors

Oct 31
Here's Why Dr. Reddy's Laboratories (NSE:DRREDDY) Has Caught The Eye Of Investors

Earnings Working Against Dr. Reddy's Laboratories Limited's (NSE:DRREDDY) Share Price

Aug 22
Earnings Working Against Dr. Reddy's Laboratories Limited's (NSE:DRREDDY) Share Price

Earnings Miss: Dr. Reddy's Laboratories Limited Missed EPS By 17% And Analysts Are Revising Their Forecasts

Jul 26
Earnings Miss: Dr. Reddy's Laboratories Limited Missed EPS By 17% And Analysts Are Revising Their Forecasts

The Dr. Reddy's Laboratories Limited (NSE:DRREDDY) Yearly Results Are Out And Analysts Have Published New Forecasts

May 13
The Dr. Reddy's Laboratories Limited (NSE:DRREDDY) Yearly Results Are Out And Analysts Have Published New Forecasts

Is Dr. Reddy's Laboratories Limited (NSE:DRREDDY) Trading At A 20% Discount?

Apr 10
Is Dr. Reddy's Laboratories Limited (NSE:DRREDDY) Trading At A 20% Discount?

Does Dr. Reddy's Laboratories (NSE:DRREDDY) Have A Healthy Balance Sheet?

Mar 02
Does Dr. Reddy's Laboratories (NSE:DRREDDY) Have A Healthy Balance Sheet?

Dr. Reddy's Laboratories Limited's (NSE:DRREDDY) Prospects Need A Boost To Lift Shares

Feb 12
Dr. Reddy's Laboratories Limited's (NSE:DRREDDY) Prospects Need A Boost To Lift Shares

With EPS Growth And More, Dr. Reddy's Laboratories (NSE:DRREDDY) Makes An Interesting Case

Dec 27
With EPS Growth And More, Dr. Reddy's Laboratories (NSE:DRREDDY) Makes An Interesting Case

CEO Compensation Analysis

How has Erez Israeli's remuneration changed compared to Dr. Reddy's Laboratories's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2025n/an/a

₹59b

Jun 30 2025n/an/a

₹57b

Mar 31 2025₹175mn/a

₹57b

Dec 31 2024n/an/a

₹54b

Sep 30 2024n/an/a

₹53b

Jun 30 2024n/an/a

₹56b

Mar 31 2024₹197mn/a

₹56b

Dec 31 2023n/an/a

₹52b

Sep 30 2023n/an/a

₹51b

Jun 30 2023n/an/a

₹47b

Mar 31 2023₹195mn/a

₹45b

Dec 31 2022n/an/a

₹36b

Sep 30 2022n/an/a

₹31b

Jun 30 2022n/an/a

₹30b

Mar 31 2022₹127mn/a

₹24b

Dec 31 2021n/an/a

₹26b

Sep 30 2021n/an/a

₹19b

Jun 30 2021n/an/a

₹17b

Mar 31 2021₹120mn/a

₹17b

Dec 31 2020n/an/a

₹21b

Sep 30 2020n/an/a

₹15b

Jun 30 2020n/an/a

₹19b

Mar 31 2020₹195m₹107m

₹19b

Dec 31 2019n/an/a

₹16b

Sep 30 2019n/an/a

₹27b

Jun 30 2019n/an/a

₹21b

Mar 31 2019₹123mn/a

₹19b

Compensation vs Market: Erez's total compensation ($USD1.96M) is above average for companies of similar size in the Indian market ($USD1.15M).

Compensation vs Earnings: Erez's compensation has been consistent with company performance over the past year.

CEO

Erez Israeli (57 yo)

7.6yrs
Tenure
₹174,720,000
Compensation

Mr. Erez Israeli, MBA has been Chief Executive Officer of Dr. Reddy's Laboratories Limited since August 1, 2019 and has been its Member of the Management Council since April 02, 2018. Mr. Israeli served as...

Leadership Team

NamePositionTenureCompensationOwnership
Gunupati Prasad
Co-Chairman39.6yrs₹188.34m13.08%
₹ 136.2b
Kallam Reddy
Chairman of the Board & Member of the Management Council32.8yrs₹118.23m13.62%
₹ 141.8b
Erez Israeli
CEO & Member of the Management Council7.6yrs₹174.72m0.039%
₹ 409.6m
Mannam Venkatanarasimham
CFO & Member of the Management Council1.3yrs₹46.00m0.0073%
₹ 75.5m
Krishna Venkatesh
Global Head of Quality and Pharmacovigilance & Member of the Management Council1.8yrs₹34.00mno data
Deepak Sapra
Global Head of Pharmaceutical Services and Active Ingredients & Member of Management Councilno data₹44.90m0.0039%
₹ 40.9m
Motupalli Ramana
CEO of Branded Markets - India & Emerging Countries and Member of Management Councilno data₹76.89m0.010%
₹ 107.9m
Archana Bhaskar
EVP, Head of Corporate Communications8.4yrs₹59.00m0.0039%
₹ 40.3m
Sanjay Sharma
Executive VP8.3yrs₹62.00mno data
Patrick Aghanian
Head of Genericsno data₹92.64mno data
Sushrut Kulkarni
Global Head of Integrated Product Development Organisation & Member of the Management Councilno data₹54.00m0.000010%
₹ 104.1k
Jayanth Sridhar
Global Head – Biologics & Member of the Management Councilno data₹33.00m0.00053%
₹ 5.5m
7.6yrs
Average Tenure
56.5yo
Average Age

Experienced Management: DRREDDY's management team is seasoned and experienced (7.6 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Gunupati Prasad
Co-Chairman39.6yrs₹188.34m13.08%
₹ 136.2b
Kallam Reddy
Chairman of the Board & Member of the Management Council32.8yrs₹118.23m13.62%
₹ 141.8b
R. Rajgopalan
Member of the Scientific Advisory Boardno data₹8.36mno data
Claudio Albrecht
Independent Director2.5yrs₹18.28mno data
Arun Kumar
Independent Director3.3yrs₹19.14mno data
Shikha Sharma
Independent Director6.8yrs₹14.86mno data
K. Reddy
Member of the Scientific Advisory Boardno datano datano data
Leo Puri
Lead Independent Director7.1yrs₹20.14mno data
Kodumudi Krishnan
Independent Director3.8yrs₹14.18mno data
Sanjiv Mehta
Independent Director1.9yrs₹15.57mno data
Alpna Seth
Independent Director2.8yrs₹17.85mno data
Penny Wan
Independent Director3.8yrs₹18.71mno data
3.8yrs
Average Tenure
65yo
Average Age

Experienced Board: DRREDDY's board of directors are considered experienced (3.8 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/11/27 07:51
End of Day Share Price 2025/11/27 00:00
Earnings2025/09/30
Annual Earnings2025/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Dr. Reddy's Laboratories Limited is covered by 77 analysts. 38 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Prashant NairAmbit Capital
Nitin BhasinAmbit Capital
Ashwin MehtaAmbit Capital